BioSpace News Archive

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces the initiation of enrollment and successful completion of the first cases of the Company’s U.S. registration C-Guardian trial of CGuard EPS.

St. Jude scientists study how phase separation begins on a microsecond time scale, showing how the earliest events with individual molecules impact assembly speed.

Tetra Therapeutics announced changes to its executive team as the company marks one year since the close of its merger with Shionogi & Co., Ltd..

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine (Spikevax) to include adolescents 12 years of age and older.

Artificial intelligence in healthcare is the use of machine-learning algorithms and software to analyze, process and present complex medical and health care data.

The report provides the trends prevailing in the global epinephrine market and the factors driving the market along with those that act as hindrances.

The Tel-Intensive Care Unit market was valued at US$ 1,031.2 million in 2017 and it is projected to reach US$ 4,884.80 million by 2025; it is expected to grow at a CAGR of 22.5% from 2018 to 2025.

China Oncology Focus, a subsidiary of Lee’s Pharm, has enrolled the first patient in the Socazolimab double-blinded Phase 3 study in combination with chemotherapy as a first-line treatment of extensive-stage small-cell lung cancer.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

The change in the ticker symbol is being made to provide greater visibility with respect to the long-term strategy of the Company.